C-peptide (C-Peptide) antibody and antigen (Recombinant protein)
Diagnostic C-peptide (C-Peptide) antibodies (anti-C-peptide, anti-C-Peptide) and antigens (recombinant C-peptide (C-Peptide) protein) for Diabetes diseases C-Peptide detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-C-Peptide-Ag01 | Recombinant human AHSG/C-Peptide/FETUA/PRO2743 Protein | 3090 |
GMP-h-C-Peptide-Ab01 | Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-C-Peptide-Ab02 | Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb) | 1953 |
GMP-h-C-Peptide-Ab03 | Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb) | 1953 |
GMP-h-C-Peptide-Ab04 | Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-C-Peptide-Ag01 |
Product Name | Recombinant human AHSG/C-Peptide/FETUA/PRO2743 Protein |
Target/Biomarker | C-peptide(C-Peptide) |
Alias of Target/Biomarker | A2HS, AHS, APMR1, FETUA, HSGA |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | C-peptide (C-Peptide) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in C-Peptide level test of Diabetes diseases (type 1 diabetes mellitus) and related syndrome evaluation. |
Products description | Recombinant human AHSG/C-Peptide/FETUA/PRO2743 Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-C-Peptide-Ab01, GMP-h-C-Peptide-Ab02 |
Product Name | Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb) |
Target/Biomarker | C-peptide(C-Peptide) |
Alias of Target/Biomarker | A2HS, AHS, APMR1, FETUA, HSGA |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human C-peptide (C-Peptide) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-peptide (C-Peptide) antibodies in C-Peptide level test of Diabetes diseases (type 1 diabetes mellitus) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human AHSG/C-Peptide/FETUA/PRO2743 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-C-Peptide-Ab03, GMP-h-C-Peptide-Ab04 |
Product Name | Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb) |
Target/Biomarker | C-peptide(C-Peptide) |
Alias of Target/Biomarker | A2HS, AHS, APMR1, FETUA, HSGA |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human C-peptide (C-Peptide) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other C-peptide (C-Peptide) antibodies in C-Peptide level test of Diabetes diseases (type 1 diabetes mellitus) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human AHSG/C-Peptide/FETUA/PRO2743 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
C-peptide is a widely used measure of pancreatic beta cell function. It is produced in equimolar amounts to endogenous insulin but is excreted at a more constant rate over a longer time. Methods of estimation include urinary and unstimulated and stimulated serum sampling. Modern assays detect levels of c-peptide which can be used to guide diabetes diagnosis and management. C-peptide is a useful and widely used method of assessing pancreatic beta cell function [1, 2]. After cleavage of proinsulin, insulin and the 31-amino-acid peptide c-peptide are produced in equal amounts [3, 4]. So why is c-peptide testing preferable to insulin as a guide to beta cell function? The degradation rate of c-peptide in the body is slower than that of insulin (half-life of 20
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.